SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Gut-First vs Brain-First Parkinson's Disease Trajectories

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-parkinsons-disease-gut-fir
Related Entities
diseases-parkinsons-disease-gut-first-vs-brain-first-trajectories
Metadata
slugdiseases-parkinsons-disease-gut-first-vs-brain-first-trajectories
entity_typedisease
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (246)
related🧫Cytochrome Therapeutics70%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice60%
mentions🧫iPSC-derived astrocyte-neuron co-culture mitochondrial trans60%
mentions🧫TLR expression in α-synuclein overexpressing mice60%
mentions🧫TLR expression analysis in Parkinson's disease patients60%
mentions🧫Dexamethasone treatment study in α-synuclein mice60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera55%
mentions🧫AAV-LRRK2 IND-Enabling Study Design55%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD55%
mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back55%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio55%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD55%
mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation55%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation55%
mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation55%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease55%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&55%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 55%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise55%
mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 55%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease55%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP55%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa55%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#55%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i55%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#55%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise55%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De55%
mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD55%
mentions🧫Ferroptosis Validation in Parkinson's Disease55%
mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD55%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&55%
mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me55%
mentions🧫Cytochrome Therapeutics55%
mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson55%
mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown55%
mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design55%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne55%
mentions🧫Macroautophagy Dysfunction in PD - Experiment Design55%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P55%
mentions🧫Validation: Membrane-Nucleation in iPSC Neurons55%
mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr55%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 55%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag55%
mentions🧫MLCS Quantification in Parkinson's Disease55%
mentions🧫Experiment: Multi-Ethnic PD GWAS55%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin55%
mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'55%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise55%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper55%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 55%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#55%
mentions🧫Parkinson's Disease Subtype Classification — Precision 55%
mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea55%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas55%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E55%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin55%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson55%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise55%
mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease55%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D55%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di55%
mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&55%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki55%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim55%
related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice54%
related🧫iPSC-derived astrocyte-neuron co-culture mitochondrial trans54%
related🧫TLR expression in α-synuclein overexpressing mice54%
related🧫TLR expression analysis in Parkinson's disease patients54%
related🧫Dexamethasone treatment study in α-synuclein mice54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Why do entorhinal cortex layer II stellate neurons die first50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬Investigate prion-like spreading of tau pathology through co40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬Why do entorhinal cortex layer II stellate neurons die first40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub